Dec 14, 2018· Comment from Association for Accessible Medicines (AAM)· FDA-2018-N-3065-0021
The Association for Accessible Medicines (AAM) is pleased to provide comments on the Food and Drug Administrations (FDAs or the Agencys) revised draft Memorandum of Understanding Addressing Certain Distributions of Compounded Drug Products Between the States and the Food and Drug Administration.